Truist Securities Reiterates Buy Rating on National Health Investors (NHI)
Tweet Send to a Friend
Truist Securities analyst Michael Lewis reiterated a Buy rating and $77.00 price target on National Health Investors (NYSE: NHI).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
